Nanopublications

Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAJDqAYeTbe57YXwaB70F1AzLnjDJ7gyn0P0f2HO-S4L0#provenance>. }

Showing items 1 to 11 of 11 with 100 items per page.

_5 label "Selventa" provenance.
_4 value "Angiotensin II (Ang II) participates in the pathogenesis of cardiovascular diseases. In hypertension, Ang II via AT1 receptors induces vascular structural changes, including cell hypertrophy, accumulation of extracellular matrix (ECM) proteins, and induction of profibrotic growth factors, such as connective tissue growth factor (CTGF).3 This growth factor also mediates cell proliferation/apoptosis, migration, cellular adhesion, wound healing, and angiogenesis.4 CTGF overexpression has been found in human atherosclerotic and myocardial lesions as well as in the aorta of Ang II?infused rats, associated with ECM accumulation. In VSMCs, CTGF acts as a downstream mediator of Ang II?induced fibrosis. The AT1 are G-coupled receptors that activate several intracellular signaling systems, such as protein kinases (MAPK and Rho kinase [ROCK]), small G proteins, including Ras, Rac1 and RhoA, transcription factors (AP-1, Smads), and redox process, which regulate several Ang II?mediated responses. In VSMCs, statins inhibited Ang II-induced Rho membrane localization and activation. In these cells Ang II regulated CTGF via RhoA/Rho kinase activation, as shown by inhibition of Rho with C3 exoenzyme, RhoA dominant-negative overexpression, and Rho kinase inhibition. " provenance.
_4 wasQuotedFrom 17592071 provenance.
assertion hadPrimarySource 17592071 provenance.
large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
large_corpus.bel description "Approximately 61,000 statements." provenance.
assertion wasDerivedFrom _4 provenance.
assertion wasDerivedFrom large_corpus.bel provenance.
large_corpus.bel authoredBy _5 provenance.
large_corpus.bel version "20131211" provenance.